3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Radiation Fibrosis Syndrome
2
Pancreatic Neoplasms
2
Pancreatic Adenocarcinoma
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Ductal Adenocarcinoma
1
Osteosarcoma
1
Neuroma, Acoustic
1
Inflammation
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Camurati-Engelmann Syndrome
1
Interventions
asciminib
8
Dasatinib
7
nilotinib
6
Imatinib Mesylate
5
Cyclophosphamide
4
ponatinib
3
fludarabine phosphate
3
bosutinib
3
Whole-Body Irradiation
3
ruxolitinib
2
letermovir
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Methotrexate
2
Melphalan
2
Cyclosporine
2
Busulfan
2
venetoclax
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
decitabine and cedazuridine drug combination
1
Vorinostat
1
Valganciclovir
1
Tyrosine Kinase Inhibitors
1
Therapeutics
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
Losartan
×
1 year
×
Clear all
No trials found.